The Effect of Vagus Nerve Stimulation on Temporomandibular Joint Dysfunction

NCT ID: NCT05500716

Last Updated: 2024-01-05

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-08-15
• Study Completion Date: 2023-11-01

Brief Summary

Temporomandibular joint dysfunction (TMD) is a broad clinical picture involving the TMJ and its disc, masticatory musculature, ligament tissue, and autonomic nervous system (ANS). TMD symptoms include decrease or excessive increase in joint range of motion (ROM), clicking sound or crepitation in the joint, pain around the joint or muscle group, chewing and swallowing problems. Pain caused by MPS, trigger point, fatigue, limitation of ROM, and ANS dysfunction cause TMD. With the inclusion of habits such as clenching and bruxism, pain, spasm and disability develop in the chewing muscles. Exposure to repeated trauma and excessive use of chewing muscles may cause the formation of tight bands and trigger points, which are characterized by MPS. When the relationship between TMD and ANS was examined, it was observed that increased sympathetic activity and decreased parasympathetic activity were effective in the severity of TMD symptoms. Auricular vagus nerve stimulation is a peripheral, non-pharmacological and non-invasive neuromodulation technique that modifies signal processing in the CNS, activates reflex circuits, exploits brain plasticity for different therapeutic purposes, thereby affecting very different areas of the brain. Non-invasive or transcutaneous Vagus Nerve Stimulation delivery systems provide stimulation in the auricular branch of the vagus nerve in the outer ear, thus eliminating the need for surgical implantation. The aim of our study is to reveal the extent to which Auricular Vagus Nerve Stimulation, applied in addition to the conventional rehabilitation program, affects the results of the treatment by stimulating the parasympathetic nervous system in patients with Temporomandibular Joint Dysfunction caused by Myofascial Pain Syndrome.

Detailed Description

The temporomandibular joint (TMJ) is a ginglymoarthrodial joint, a term derived from ginglymus, meaning a hinge joint that allows only forward and backward movement in one plane, and arthrodia, a joint that allows gliding motion, and right and left TMJ are similar to knee articulation. It forms the ellipsoid variety of bicondylar articulation and synovial joints. TMJ movements are defined as elevation, depression, protrusion, retrusion, and lateralization. Primary muscle groups that reveal these joint movements m. masseter, m. temporalis, medial and lateral pterygoid, suprahyoid (digastricus, mylohyoid, geniohyoid, stylohyoid) and infrahyoid (thyrohyoid, sternohyoid, sternothyroid, omohyoid). The TMJ ligament complex consists of superficial and deep collateral ligament, sphenomandibular ligament and stylomandibular ligament. While the sensory nerves of the TMJ branch from the Trigeminal (V. Cranial nerve) nerve, they receive sympathetic innervation from the cervical ganglion (C8-T3). Temporomandibular joint dysfunction (TMD) is a broad clinical picture involving the TMJ and its disc, masticatory musculature, ligament tissue, and autonomic nervous system (ANS). TMD symptoms include decrease or excessive increase in joint range of motion (ROM), clicking sound or crepitation in the joint, pain around the joint or muscle group, chewing and swallowing problems. TMD is considered in two groups as articular and non-articular disorders: articular disorders express the dislocation of the disc with and without reduction, while non-articular disorders express the problems caused by myofascial pain syndrome (MPS). Pain caused by MPS, trigger point, fatigue, limitation of ROM, and ANS dysfunction cause TMD. With the inclusion of habits such as clenching and bruxism, pain, spasm and disability develop in the chewing muscles. Exposure to repetitive trauma and overuse of chewing muscles may cause the formation of tight bands and trigger points, which are characterized by MPS.

ANS is part of the peripheral nervous system (PSS), which regulates involuntary physiological processes such as heart rate, blood pressure, respiration, and digestion, and is anatomically composed of 3 parts: the sympathetic, parasympathetic, and enteric nervous systems. The sympathetic nervous system (SNS) and parasympathetic nervous system (PNS) contain afferent and efferent pathways that provide sensory and motor stimulation, and these pathways consist of preganglionic neurons in the central nervous system (CNS) and postganglionic neurons in the periphery. The SNS enables the body to handle stressors through the "fight or flight" response, and this reaction primarily regulates the blood vessels. The vessels are tonically innervated and in most cases an increase in sympathetic signals leads to vasoconstriction. SNS activation increases heart rate and contraction force. The PNS exits the SNS via cranial nerves III, VII, IX, and X, as well as via S2-4 nerve roots. The vagus nerve (Cranial Nerve X), together with the sacral parasympathetic fibers, provides parasympathetic input to most of the thoracic and abdominal organs and has four cell bodies: Dorsal nucleus (parasympathetic stimulation of viscera), Nucleus ambiguous (preganglionic neurons innervating the heart), Nucleus solitarius (taste sense) and Trigeminal nucleus (outer ear circumference receives touch, pain and temperature information). The vagus nerve is responsible for the "resting and digesting" processes. By providing cardiac relaxation, the vagus nerve reduces contraction in the atria and ventricles and decreases the conduction velocity through the atrioventricular node. The vagus nerve also has a significant effect on the respiratory cycle, and its activity increases during expiration, constricting and stiffening the airways to prevent lung collapse.

When the relationship between TMD and ANS was examined, it was observed that increased sympathetic activity and decreased parasympathetic activity were effective in the severity of TMD symptoms. It has been shown that TMD patients may show changes in the sympathoadrenal and inflammatory cytokine function resulting from their response to the stressor, and that the increase in the sympathetic activity of these patients in the long term may cause decreased interleukin-6 (IL-6) and norepinephrine response. It is thought that IL-6 may be an important factor related to the increased morbidity and mortality in people with chronic stress and may play a pathogenic role in the course of stress-reactive chronic diseases. Another mechanism thought to cause TMD is that the junctional region between the trigeminal subnucleus caudalis (Vc) and the upper cervical spinal cord, called the Vc/C1-2 region, is the primary site for synaptic integration of sensory input from TMJ nociceptors, and Vc/C1- It is known that estrogen hormone is effective on the processing of nociceptive stimulus by neurons in region 2. Especially in the post-menopausal period, the decrease in the level of estrogen in the blood causes an increase in sympathetic activity and causes pain and disability around the TMJ. Another method of evaluating the relationship between TMD and ANS is the measurement of heart rate variability (HRV). In a study, it was observed that HRV, which is a marker of ANS dysfunction, decreased in patients with myofascial temporomandibular disorder (TMD) compared to healthy individuals.

Auricular vagus nerve stimulation is a peripheral, non-pharmacological and non-invasive neuromodulation technique that modifies signal processing in the CNS, activates reflex circuits, exploits brain plasticity for different therapeutic purposes, thereby affecting very different areas of the brain. Modulation of the afferent vagus nerve affects numerous physiological processes and bodily states associated with the transfer of information between the brain and the body. These include disease mitigating effects and sustainable therapeutic practices ranging from chronic pain diseases, neurodegenerative and metabolic disorders to inflammatory and cardiovascular diseases. Non-invasive or transcutaneous Vagus Nerve Stimulation delivery systems provide stimulation in the auricular branch of the vagus nerve in the outer ear, thus eliminating the need for surgical implantation. One of the non-invasive Vagus Nerve Stimulators in use today, NEMOS®, stimulates the outer ear turbinate and is European Conformity (CE) marked for the European Union for the management of epilepsy. The electrode is connected to a stimulation box and the stimulation intensity can be adjusted by the patient, caregiver, or treating healthcare professional. During use, it is increased in 0.1 milliamperes(mA) steps until the detection threshold of electrical stimulation is reached; the stimulation frequency was defined as 25 Hz. Another non-invasive Vagus Nerve Stimulator gammaCore® is used for transcutaneous stimulation of the cervical branch of the vagus nerve and is FDA approved for the treatment of episodic cluster headache. The device generates a wave in the form of a pulse. It creates impulses with a 1 ms transition time of an electrical current with a frequency of 25 Hz. The recommended stimulation time is 2 minutes and can be applied up to 12 times a day.

Conditions

Temporomandibular Joint Dysfunction Syndrome; Autonomic Nervous System Imbalance

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Auricular Non-Invasive Vagus Nerve Stimulation+Traditional Rehabilitation Program

• Auricular Non-Invasive Vagus Nerve Stimulation
• Deep Friction Massage
• Myofascial Trigger Point Compression Therapy
• Temporomandibular Joint Mobilization
• Rocabado Exercises
• Muscle-Energy Techniques

Group Type: EXPERIMENTAL

Auricular Non-Invazive Vagus Nerve Stimulation + Traditional Rehabilitation Program for TMD

Intervention Type: OTHER

In this application, vagus nerve stimulation is applied to the patients in addition to the traditional rehabilitation program. In our research, vagal nerve stimulation will be applied with the "Vagustim" Device and all applications will be applied at a frequency of 10 Hz, a pulse amplitude of 300 microseconds and for 20 minutes.

Traditional Rehabilitation Program

• Deep Friction Massage
• Myofascial Trigger Point Compression Therapy
• Temporomandibular Joint Mobilization
• Rocabado Exercises
• Muscle-Energy Techniques

Group Type: ACTIVE_COMPARATOR

Traditional Rehabilitation Program

Intervention Type: OTHER

This intervention includes: Deep Friction Massage, Myofascial Trigger Point Compression Therapy, Temporomandibular Joint Mobilization, Rocabado Exercises, Muscle-Energy Techniques.

Interventions

Auricular Non-Invazive Vagus Nerve Stimulation + Traditional Rehabilitation Program for TMD

In this application, vagus nerve stimulation is applied to the patients in addition to the traditional rehabilitation program. In our research, vagal nerve stimulation will be applied with the "Vagustim" Device and all applications will be applied at a frequency of 10 Hz, a pulse amplitude of 300 microseconds and for 20 minutes.

Intervention Type: OTHER

Traditional Rehabilitation Program

This intervention includes: Deep Friction Massage, Myofascial Trigger Point Compression Therapy, Temporomandibular Joint Mobilization, Rocabado Exercises, Muscle-Energy Techniques.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Compliant with temporomandibular disorders research/diagnosis criteria,
• Diagnosed with Myofascial Pain Syndrome,
• 18 years and over,
• Female patients who volunteered to participate in the study and filled in the informed consent form will be included in the study.

Exclusion Criteria

• History of TMJ disc dislocation,
• History of acute trauma in and around the TMJ,
• Having a history of surgical/invasive procedures on the TMJ,
• Having a neurological or psychiatric diagnosis,
• Being pregnant,
• Presence of infection or tumoral structure within intraoral structures
• Having a history of tooth loss, use of prosthetic teeth,
• Having a history of surgical procedures in the cervical region,
• Previous treatment related to TMD,
• be under the age of 18,
• Participants will be excluded from the study if they are in the post-menopausal stage.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Alper Percin

OTHER

Sponsor Role: lead

Responsible Party

Alper Percin

Principle İnvestigator

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Hande Başat, M.D.

Role: STUDY_DIRECTOR

Bahçeşehir University

Locations

Bahçeşehir University

Istanbul, Beşiktaş, Turkey (Türkiye)

Countries

Turkey (Türkiye)

References

Kisilewicz A, Janusiak M, Szafraniec R, Smoter M, Ciszek B, Madeleine P, Fernandez-de-Las-Penas C, Kawczynski A. Changes in Muscle Stiffness of the Trapezius Muscle After Application of Ischemic Compression into Myofascial Trigger Points in Professional Basketball Players. J Hum Kinet. 2018 Oct 15;64:35-45. doi: 10.2478/hukin-2018-0043. eCollection 2018 Sep.

Reference Type: BACKGROUND

PMID: 30429897 (View on PubMed)

Ishii H, Koga H, Takanishi A, Katsumata A. Development and experimental evaluation of Oral Rehabilitation Robot that provides maxillofacial massage to patients with oral disorders. Int J Robotics Res. 2009;28:May 19. DOI: doi:10,1177/0278364909104295

Reference Type: BACKGROUND

Gillespie BR. Assessment and treatment of TMJ muscles, fascia, ligaments, and associated structures. Cranio. 1990 Jan;8(1):51-4. doi: 10.1080/08869634.1990.11678300.

Reference Type: RESULT

PMID: 2098188 (View on PubMed)

Ohrbach R, Dworkin SF. Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables. Pain. 1998 Feb;74(2-3):315-26. doi: 10.1016/s0304-3959(97)00194-2.

Reference Type: RESULT

PMID: 9520246 (View on PubMed)

Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992 Fall;6(4):301-55. No abstract available.

Reference Type: RESULT

PMID: 1298767 (View on PubMed)

Travell JG, Simons DG. Myofascial pain and dysfunction: The trigger point manual. Baltimore: Williams and Wilkins; 5-90,1983.

Reference Type: RESULT

Ohrbach R, Michelotti A. The Role of Stress in the Etiology of Oral Parafunction and Myofascial Pain. Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):369-379. doi: 10.1016/j.coms.2018.04.011. Epub 2018 Jun 1.

Reference Type: RESULT

PMID: 29866454 (View on PubMed)

Eisenlohr-Moul TA, Crofford LJ, Howard TW, Yepes JF, Carlson CR, de Leeuw R. Parasympathetic reactivity in fibromyalgia and temporomandibular disorder: associations with sleep problems, symptom severity, and functional impairment. J Pain. 2015 Mar;16(3):247-57. doi: 10.1016/j.jpain.2014.12.005. Epub 2014 Dec 24.

Reference Type: RESULT

PMID: 25542636 (View on PubMed)

Costello NL, Bragdon EE, Light KC, Sigurdsson A, Bunting S, Grewen K, Maixner W. Temporomandibular disorder and optimism: relationships to ischemic pain sensitivity and interleukin-6. Pain. 2002 Nov;100(1-2):99-110. doi: 10.1016/s0304-3959(02)00263-4.

Reference Type: RESULT

PMID: 12435463 (View on PubMed)

Tashiro A, Bereiter DA. The effects of estrogen on temporomandibular joint pain as influenced by trigeminal caudalis neurons. J Oral Sci. 2020 Mar 28;62(2):150-155. doi: 10.2334/josnusd.19-0405. Epub 2020 Mar 4.

Reference Type: RESULT

PMID: 32132330 (View on PubMed)

Eze-Nliam CM, Quartana PJ, Quain AM, Smith MT. Nocturnal heart rate variability is lower in temporomandibular disorder patients than in healthy, pain-free individuals. J Orofac Pain. 2011 Summer;25(3):232-9.

Reference Type: RESULT

PMID: 21837290 (View on PubMed)

Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines RF, Papa M, Kiss A, Podesser B, Cassara AM, Tanghe E, Samoudi AM, Tarnaud T, Joseph W, Marozas V, Lukosevicius A, Istuk N, Sarolic A, Lechner S, Klonowski W, Varoneckas G, Szeles JC. Current Directions in the Auricular Vagus Nerve Stimulation I - A Physiological Perspective. Front Neurosci. 2019 Aug 9;13:854. doi: 10.3389/fnins.2019.00854. eCollection 2019.

Reference Type: RESULT

PMID: 31447643 (View on PubMed)

Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015 Sep;22(9):1260-8. doi: 10.1111/ene.12629. Epub 2015 Jan 23.

Reference Type: RESULT

PMID: 25614179 (View on PubMed)

Jeong KH, Kim ME, Kim HK. Temporomandibular disorders and autonomic dysfunction: Exploring the possible link between the two using a questionnaire survey. Cranio. 2023 Sep;41(5):467-477. doi: 10.1080/08869634.2021.1872313. Epub 2021 Jan 11.

Reference Type: RESULT

PMID: 33427101 (View on PubMed)

Monaco A, Cattaneo R, Mesin L, Ciarrocchi I, Sgolastra F, Pietropaoli D. Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study. PLoS One. 2012;7(9):e45424. doi: 10.1371/journal.pone.0045424. Epub 2012 Sep 18.

Reference Type: RESULT

PMID: 23028999 (View on PubMed)

Robinson LJ, Durham J, MacLachlan LL, Newton JL, Autonomic function in chronic fatigue syndrome with and without painful temporomandibular disorder. Pages 205-219 | Received 22 May 2015, Accepted 28 Aug 2015, Published online: 05 Oct 2015. https://doi.org/10.1080/21641846.2015.1091152

Reference Type: RESULT

Gomes NC, Berni-Schwarzenbeck KC, Packer AC, Rdrigues-Bigaton D. Effect of cathodal high-voltage electrical stimulation on pain in women with TMD. Rev Bras Fisioter. 2012 Jan-Feb;16(1):10-5. English, Portuguese.

Reference Type: RESULT

PMID: 22441222 (View on PubMed)

Blanco-Aguilera A, Blanco-Hungria A, Biedma-Velazquez L, Serrano-Del-Rosal R, Gonzalez-Lopez L, Blanco-Aguilera E, Segura-Saint-Gerons R. Application of an oral health-related quality of life questionnaire in primary care patients with orofacial pain and temporomandibular disorders. Med Oral Patol Oral Cir Bucal. 2014 Mar 1;19(2):e127-35. doi: 10.4317/medoral.19061.

Reference Type: RESULT

PMID: 24121906 (View on PubMed)

Gil-Martinez A, Paris-Alemany A, Lopez-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res. 2018 Mar 16;11:571-587. doi: 10.2147/JPR.S127950. eCollection 2018.

Reference Type: RESULT

PMID: 29588615 (View on PubMed)

Vijila JY. (2016). Effectiveness of Muscle Energy Technique and Rocabado Exercise Versus Therapeutic Jaw Exercises for Temporomandibular Joint Dysfunction (Doctoral dissertation, Nandha College of Physiotherapy, Erode).

Reference Type: RESULT

Percin A, Basat H, Ozden AV, Yenisehir S. The effect of auricular vagus nerve stimulation in women with temporomandibular joint disorders: a randomized controlled study. Rev Assoc Med Bras (1992). 2025 Jun 2;71(4):e20241739. doi: 10.1590/1806-9282.20241739. eCollection 2025.

Reference Type: DERIVED

PMID: 40465996 (View on PubMed)

Other Identifiers

STUDYAP0001

Identifier Type: -

Identifier Source: org_study_id